IRIS PubliCatt

Pandolfi, Franco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.035
EU - Europa 2.720
AS - Asia 825
SA - Sud America 17
OC - Oceania 16
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.618
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.015
DE - Germania 792
SE - Svezia 511
UA - Ucraina 489
CN - Cina 453
IE - Irlanda 210
IT - Italia 198
SG - Singapore 195
FR - Francia 167
FI - Finlandia 114
GB - Regno Unito 78
IN - India 75
RU - Federazione Russa 74
TR - Turchia 27
JP - Giappone 23
BE - Belgio 19
AU - Australia 15
PL - Polonia 15
CA - Canada 14
HK - Hong Kong 13
IR - Iran 10
VN - Vietnam 10
CH - Svizzera 9
NL - Olanda 9
ES - Italia 7
AR - Argentina 6
CL - Cile 6
IL - Israele 4
MK - Macedonia 4
MX - Messico 4
RO - Romania 4
BR - Brasile 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
KR - Corea 3
RS - Serbia 3
AT - Austria 2
ID - Indonesia 2
IS - Islanda 2
MY - Malesia 2
NO - Norvegia 2
PH - Filippine 2
PT - Portogallo 2
RE - Reunion 2
SA - Arabia Saudita 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BO - Bolivia 1
BZ - Belize 1
EU - Europa 1
HU - Ungheria 1
KW - Kuwait 1
NZ - Nuova Zelanda 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
ZA - Sudafrica 1
Totale 6.618
Salva come PNG Salva come JPEG
Città #
Chandler 515
Ashburn 340
Jacksonville 251
San Mateo 204
Dublin 202
Singapore 130
Wilmington 118
Ann Arbor 108
Nanjing 107
Lawrence 86
Boston 79
Cattolica 72
Dearborn 67
Moscow 61
Houston 56
Beijing 52
Woodbridge 52
Fairfield 47
Redwood City 46
Boardman 45
Seattle 41
Marseille 34
Nürnberg 33
Mountain View 32
New York 32
Nanchang 31
Shenyang 30
University Park 30
Hebei 29
Lancaster 29
Detroit 27
Hangzhou 27
Princeton 23
Izmir 21
Milan 21
Los Angeles 20
Bremen 19
Cambridge 19
Chicago 19
Norwalk 19
Jiaxing 18
Brussels 17
Changsha 17
Helsinki 17
Rome 17
Munich 14
Shanghai 14
Kraków 13
Tianjin 13
Zhengzhou 13
Jinan 12
Washington 12
Guangzhou 11
Fremont 10
Hanoi 10
Hefei 10
Pune 10
Kunming 9
Leawood 9
Simi Valley 9
Busto Arsizio 8
Hong Kong 8
Bareggio 7
Encino 7
Zola Predosa 7
Bern 6
Edinburgh 6
Falls Church 6
Kish 6
Paris 6
Philadelphia 6
Ypsilanti 6
Indiana 5
Ningbo 5
Verona 5
Augusta 4
Chengdu 4
London 4
Montréal 4
Prilep 4
Sydney 4
Tappahannock 4
Ankara 3
Atlanta 3
Barrie 3
Bilbao 3
Fuzhou 3
Norfolk 3
Padova 3
Port Orchard 3
Raleigh 3
San Francisco 3
San Giorgio del Sannio 3
Serooskerke 3
Taizhou 3
Tokyo 3
Ashland 2
Bangalore 2
Belgrade 2
Berlin 2
Totale 3.601
Salva come PNG Salva come JPEG
Nome #
Can vitamin a mediate immunity and inflammation? 124
Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet. 107
The role of IL-15 in gastrointestinal diseases: a bridge between innate and adaptive immune response 107
Skewed T-cell receptor repertoire: more than a marker of malignancy, a tool to dissect the immunopathology of inflammatory diseases 106
Key Role of DAMP in Inflammation, Cancer, and Tissue Repair 101
Relationship between gastric localization of hepatitis C virus and mucosa-associated lymphoid tissue in Helicobacter pylori infection 100
Role of vitamins D, E and C in immunity and inflammation. 100
Comment on: Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system. 99
Reflux symptoms in wind instrument players. 99
How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology 97
Uncomplicated Diverticular Disease: Innate and Adaptive Immunity in Human Gut Mucosa before and after Rifaximin 96
Recent insights in primary immunodeficiency diseases: the role of T-lymphocytes and innate immunity. 95
Common variable immunodeficiency - new insight into the pathogenesis and the quest for a workable classification. 88
Central and Mucosal Immunities are Modified by Non Adsorbable Antibiotic Treatment in Uncomplicated Diverticular Disease 88
T-cell receptor repertoire and function in patients with Di George Syndrome and velocardiofacial syndrome. 86
The immune response to tumors as a tool toward immunotherapy 85
Third-line rescue therapy for Helicobacter pylori infection 84
Skewed T-cell receptor repertoire: more than a marker of malignancy, a tool to dissect the immunopathology of inflammatory diseases 84
TLR2: a crossroads between infections and autoimmunity? 83
IL-32: a newly-discovered proinflammatory cytokine 82
The Interaction among Microbiota, Immunity, and Genetic and Dietary Factors Is the Condicio Sine Qua Non Celiac Disease Can Develop 81
Third-line rescue therapy for Helicobacter pylori infection. 80
Allele *1 of HS1.2 enhancer associates with selective IgA deficiency and IgM concentration 78
Allele*1 of HS1,2 enhancer associates with selective IgA deficiency and IgM concentration 77
The importance of complying with vaccination protocols in developed countries: "anti-vax" hysteria and the spread of severe preventable diseases 77
Luteolin inhibits mast cell-mediated allergic inflammation. 76
Immune Modulation by Vitamin D: Special Emphasis on Its Role in Prevention and Treatment of Cancer. 76
Comment on: Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system 71
New insights on the role of T-cels in the pathogenesis of Celiac Disease 71
Cellular mediators of inflammation: tregs and t(h)17 cells in gastrointestinal diseases. 71
The involvement of IgH enhancer HS1.2 in the pathogenesis of Crohn's disease: how the immune system can influence a multifactorial disease 71
Interleukin-6 in Rheumatoid Arthritis 71
Cellular mediators of inflammation: tregs and TH17 cells in gastrointestinal diseases. 70
Impairment of recent thymic emigrants in HCV infection. 69
New insights on the role of T cells in the pathogenesis of celiac disease. 69
Low-dose IL-2 reduces lymphocyte apoptosis and increases naive CD4 cells in HIV-1 patients treated with HAART 68
Increased osteoclastic activity in acute Charcot's osteoarthopathy: the role of receptor activator of nuclear factor-kappa B ligand 67
Strategies to overcome obstacles to successful immunotherapy of melanoma 65
BALKAN ENDEMIC NEPHROPATHY RISK ASSOCIATES TO THE HS1.2 IG ENHANCER POLYMORPHISM 65
Melanoma antigen recognition by tumor-infiltrating T lymphocytes (TIL): effect of differential expression of melan-A/MART-1 63
Impact of IL-18 on inflammation 63
Increased frequency of Ig heavy-chain HS1,2-A enhancer *2 allele in dermatitis herpetiformis, plaque psoriasis, and psoriatic arthritis. 63
The impact of biological agents interfering with receptor/ligand binding in the immune system. 62
Activity of caffeic acid derivatives against Candida albicans biofilm 62
VEGF, substance P and stress, new aspects: a revisited study. 62
Apoptosis in asymptomatic HIV-1 seropositives immunized with HIV-1 env glycoprotein (gp160): effects of administration of Zidovudine in vivo and IL-2 in vitro 62
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 61
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 61
Impact of Fungi on Immune Responses 58
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 58
Current Challenges in Immunology 57
Apoptosis in the homeostasis of the immune system and in human immune mediated diseases 56
TLR2: a crossroads between infections and autoimmunity? 56
Mast cell involvement in rheumatoid arthritis. 56
Abnormal synthesis of IgA in coeliac disease and related disorderd 55
Tissue infiltrating lymphocytes: the role of cytokines in their growth and differentiation. 54
Mast Cells Mediate Rheumatoid Arthritis-Inhibitory Role of IL-37 54
Luteolin, inflammation and cancer: Special emphasis on gut microbiota 54
The number of HIV-DNA infected mononuclear cells is reduced under HAART plus recombinant IL-2. 53
Vitamins and mast cells. 53
Integrins: Integrating the Biology and Therapy of Cell-cell Interactions 53
High prevalence of hyperplastic colonic polyps in acromegalic subjects. 52
Nutrition and cancer prevention 52
The Italian quality control study for evaluation of CD4 cells in centres involved in the treatment of HIV-1 patients. Italian CD4 Quality Control Group 51
Strategies to overcome obstacles to successful immunotherapy of melanoma. 51
IL-31 a Th2 cytokine involved in immunity and inflammation. 51
Involvment of central immunity in uncomplicated diverticular disease. 51
Heat shock protein-90 inhibitors enhance antigen expression on melanomas and increase T cell recognition of tumor cells 51
Induction of "antigen silencing" in melanomas by oncostatin M: downmodulation of melanocyte antigen expression. 50
Changes in host cell molecules acquired by circulating HIV-1 in patients treated with highly active antiretroviral therapy and interleukin-2. 50
Active thymopoiesis in idiopathic chronic pancreatitis 50
Comparison of beneficial actions of non-steroidal anti-inflammatory drugs to flavonoids 49
A novel autocrine pathway of tumor escape immune recognition; melanoma cell produce a soluble protein that diminuishes expression of the gene encoding the melanocyte lineage melan-A/MART-1 antigen through down modulation of its promoter. 48
IgE generation and mast cell activation 48
Studies of the mechanism of cytolysis by tumour-infiltrating lymphocytes 47
Gut microbiota and immunity in common variable immunodeficiency: crosstalk with pro-inflammatory cytokines 47
New insight into systemic mastocytosis mediated by cytokines IL-1 beta and IL-33: Potential inhibitory effect of IL-37 47
HIV type 1-induced inhibition of CD45 tyrosine phosphatase activity correlates with disease progression and apoptosis, but not with anti-CD3-induced T cell proliferation 46
Epatite da farmaci 46
HCV co-infection does not affect the TREC/IL-7 pathway in HIV disease 46
Impact of mast cells in rejection of allografts 46
Biased T cell receptor repertoires in patients with chromosome 22q11.2 deletion syndrome (Di George syndrome/velocardiofacial syndrome) 45
Structure and expression of the human ubiquitin fusion-degradation gene (UFD1L). 45
Decreased CD 95 expression on naive T cells from HIV infected persons undergoing highly active antiretroviral therapy (HAART) and the influence of IL-2 low dose administration 44
Nerve growth factor interactions with mast cells 44
Interrelationship between IL-3 and mast cells 44
Increased frequency of the immunoglobulin enhancer HS1,2 allele 2 in coeliac disease 44
Nickel allergy in lipid transfer protein sensitized patients: Prevalence and clinical features 44
Vascular endothelial growth factor (VEGF), mast cells and inflammation. 43
VEGF, substance P and stress, new aspects: a revisited study 43
Apoptotic effect of cyclosporin a and dexamethasone in malignant cells of patients with B-chronic lymphocytic leukemia. 42
Role of mast cells in innate and adaptive immunity. 42
Impact of capsaicin on mast cell inflammation. 42
Impact of mast cells on the skin. 42
IL-36 receptor antagonist with special emphasis on IL-38. 39
Oligoclonality of Vdelta1 and Vdelta2 cells in human peripheral blood mononuclear cells: TCR selection is not altered by stimulation with gram-negative bacteria 38
Impact of IL -9 and IL-33 in mast cells 38
Sudden coronary death, fatal acute myocardial infarction and widespread coronary and myocardial inflammation 37
Impact of immunity in autism spectrum disorders 37
Adequate patient's outcome achieved with short immunoglobulin replacement intervals in severe antibody deficiencies 37
Totale 6.329
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.733
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.733
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020536 0 0 40 18 27 54 77 28 37 31 107 117
2020/2021973 51 104 13 108 132 76 129 24 111 16 182 27
2021/2022857 65 125 14 62 46 32 11 118 38 44 116 186
2022/20231.573 229 181 152 207 155 201 55 94 166 42 60 31
2023/2024900 30 279 23 129 27 100 23 44 21 39 92 93
2024/2025118 46 72 0 0 0 0 0 0 0 0 0 0
Totale 6.679